Penicilliosis

Essentials of Clinical Mycology: Second Edition

Volumn , Issue , 2011, Pages 399-411

  Nelson, Kenrad E ^a   Supparatpinyo, Khuanchai ^b   Vanittanakom, Nongnuch ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876010737     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-6640-7_23     Document Type: Chapter

References (113)

1. Capponi M, Segretain G, Sureau P. Penicillosis from Rhizomys sinensis. Bull Soc Pathol Exot Filiales. 1956;49:418-21.
2. Segretain G. Description d'une nouvelle espiece de pencillium: Penicillium marneffei n. sp. Bull Soc Mycol France. 1959;75:412-6.
3. DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol. 1973;60:259-63.
4. Pautler KB, Padhye AA, Ajello L. Imported penicilliosis marneffei in the United States: report of a second human infection. Sabouraudia. 1984;22:433-8.
5. Jayanetra P, Nitiyanant P, Ajello L, et al. Penicilliosis marneffei in Thailand: report of five human cases. Am J Trop Med Hyg. 1984;33:637-44.
6. Deng ZL, Connor DH. Progressive disseminated penicilliosis caused by Penicillium marneffei. Report of eight cases and differentiation of the causative organism from Histoplasma capsulatum. Am J Clin Pathol. 1985;84:323-7.
7. Li JS, Pan LQ, Deng ZL, Yoo CL. A case report on Penicillium marneffei. J Clin Dermatol (China). 1985;14:24-6.
8. Li JS, Pan LQ, Wu SX. Mycologic investigation on Rhizomys pruinosus senex in Guangxi as natural carrier with Penicillium marneffei. Clin Med J. 1989;102:477-85.
9. Li JS, Pan Q, Wu SX, Su SX, Su B, Shan JH. Diseminated Penicilliosis marneffei in China: report of three cases. Clin Med J. 1991;104:247-51.
10. Hilmarsdottir I, Meynard JL, Rogeaux O, Gentilini M. Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: A report of two cases and a review of 35 published cases. J Acquir Immune Defic Syndr. 1993;6:466-71.
11. Hulshof CM, van Zanten RA, Sluiters JF, et al. Penicillium marneffei infection in an AIDS patient. Eur J Clin Microbiol Infect Dis. 1990;9:370.
12. Jones PD, Sees J. Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity. Clin Infect Dis. 1992;15:744.
13. Kronauer CM, Schar G, Barben M, Buhler H. HIV-associated Penicillium marneffei infection. Schweiz Med Wochenschr. 1993; 123:385-90.
14. Peto TE, Bull R, Millard PR, et al. Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus. J Infect. 1988;16:285-90.
15. Piehl MR, Kaplan RL, Haber MH. Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1988;112:1262-4.
16. Sobottka I, Albrecht H, Mack D, et al. Systemic Penicillium marneffei infection in a German AIDS patient. Eur J Clin Microbiol Infect Dis. 1996;15:256-9.
17. Viviani MA, Tortoranto AM, Rizzardini G, et al. Treatment and serological studies of an Italian case of Penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus. Eur J Epidemiol. 1993;9:79-85.
18. Hilmarsdottir I, Coutellier A, Elbaz J, et al. A French case of laboratory- Acquired disseminated Penicillium marneffei infection in a patient with AIDS (letter). Clin Infec Dis. 1994;19:357-8.
19. Nelson KE, Kaufman L, Cooper CR, Merz WG. Penicillium marneffei: An AIDS-related illness from Southeast Asia. Infect Med. 1999;16:118-21.
20. Supparatpinyo K, Chiewchanvit S, Hirunsri P, Uthammachai C, Nelson KE, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992; 14:871-4.
21. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994;344:110-3.
22. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Nelson KE. Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: A clue to the reservoir? J Infect Dis. 1996;173:1490-3.
23. Deng Z, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis. 1988;10:640-52.
24. Deng ZL, Yun M, Ajello L. Human penicilliosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus). J Med Vet Mycol. 1986;24:383-9.
25. Wei XG, Ling YM, Li C, Zhang FS. Study of 179 bamboo rats carrying Penicillium marneffei (in Chinese). China J Zoonoses. 1987;3:34-5.
26. Ajello L, Padhye AA, Sukroongreung S, Nilakul CH, Tantimavanic S. Occurrence of Penicillium marneffei infections among wild bamboo rats in Thailand. Mycopathologia. 1995;131:1-8.
27. Chariyalertsak S, Vanittanakom P, Nelson KE, Sirisanthana T, Vanittanakom N. Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei. J Med Vet Mycol. 1996;34:105-10.
28. Gugnani H, Fisher MC, Paliwal-Johsi A, Vanittanakom N, Singh I, Yadav PS. Role of Cannomys badius as a natural animal host of Penicillium marneffei in India. J Clin Microbiol. 2004; 42:5070-5.
29. Segretain G. Penicillium marneffei n.sp.agent d'une mycose du système reticuloendothelial. Mycopath Mycolgia Appl. 1959; 11:327-53.
30. Vanittanakom N, Mekaprateep M, Sriburee P, Vanittanakom P, Khanjanasthiti P. Efficiency of the flotation method in the isolation of Penicillium marneffei from seeded soil. J Med Vet Mycol. 1995; 33:271-3.
31. Corbet GB, Hill JE. Subfamily Rhizomyinae: bamboo rats. In: The mammals of the Indo Malaya region: A systemic review. New York: Oxford University Press; 1992. p. 404-7.
32. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Praparattanapan J, Nelson KE. Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand. Clin Infect Dis. 1997;24:1080-6.
33. Chariyalertsak S, Sirisanthana T, Saengwonloey O, Nelson KE. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: regional variation and temporal trends. Clin Infect Dis. 2001;32:955-62.
34. Raper KB, Thom CA. A manual of the penicillia. Baltimore: The Williams and Wilkins Co; 1949.
35. Pitt JI. The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces. New York: Academic Press Inc; 1979.
36. LoBuglio KF, Taylor JW. Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei. J Clin Microbiol. 1995;33:85-9.
37. Sekhon AS, Li JS, Garg AK. Penicillosis marneffei: Serological and exoantigen studies. Mycopathologia. 1982;77:51-7.
38. Wong SS, Ho TY, Ngan AH, Woo PC, Que TL, Yuen KY. Biotyping of Penicillium marneffei reveals concentration-dependent growth inhibition by galactose. J Clin Microbiol. 2001;39:1416-21.
39. Hamilton AJ, Jeavons L, Youngchim S, Vanittanakom N, Hay RJ. Sialic acid-dependent recognition of laminin by Penicillium marneffei conidia. Infect Immun. 1998;66:6024-6.
40. Hamilton AJ, Jeavons L, Youngchim S, Vanittanakom N. Recognition of fibronectin by Penicillium marneffei conidia via a sialic aciddependent process and its relationship to the interaction between conidia and laminin. Infect Immun. 1999;67:5200-5.
41. Sekhon AS, Padhye AA, Garg AK. In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents. Eur J Epidemiology. 1992;8:427-32.
42. Drouhet E. Penicilliosis due to Penicillium marneffei: A new emerging sysemic mycosis in AIDS patients traveling or living in Southeast Asia, Review of 44 cases reported in HIV infected patients during the last 5 years compared to 44 cases of non AIDS patients reported over 20 years. J Mycol Med (Paris). 1993;4:195-224.
43. Supparatpinyo K, Nelson KE, Merz WG, et al. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother. 1993;37:2407-11.
44. Imwidthaya P, Thipsuvan K, Chaiprasert A, Danchaivijitra S, Suthent R, Jearanaisilavong J. Penicillium marneffei: Types and drug susceptibility. Mycopathologia. 2001;149:109-15.
45. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109, 496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother. 1997;41:841-3.
46. Sar B, Boy S, Keo C, et al. In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia. J Clin Microbiol. 2006;44:4208-10.
47. Hilmarsdottir I, Meynard JL, Rogeaux O, et al. Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: A report of two cases and a review of 35 published cases. J Acquir Immune Defic Syndr. 1993;6:466-71.
48. Viviani MA, Tortorano AM, Rizzardini G, et al. Treatment and serological studies of an Italian case of Penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus. Eur J Epidemiol. 1993;9:79-85.
49. Rongruagruang Y, Levitz SM. Interaction of Penicillium marneffei with human leukocytes in vitro. Infect Immun. 1999;67:4732-6.
50. Vanittanakom N, Cooper Jr. CR, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19:95-110.
51. Woods JP. Histoplasma capsulatum molecular genetics, pathogenesis, and responsiveness to its environment. Fungal Genet Biol. 2002;35:81-97.
52. Pongpom P, Cooper Jr. CR, Vanittanakom N. Isolation and characterization of a catalase-peroxidase gene from the pathogenic fungus, Penicillium marneffei. Med Mycol. 2005;43:403-11.
53. Thirach S, Cooper Jr. CR, Vanittanakom P, Vanittanakom N. The copper, zinc superoxide dismutase gene of Penicillium marneffei: cloning, characterization, and differential expression during phase transition and macrophage infection. Med Mycol. 2007;45:409-17.
54. Bastos KP, Bailao AM, Borges CL, et al. The transcriptome analysis of early morphogenesis in Paracoccidioides brasiliensis mycelium reveals novel and induced genes potentially associated to the dimorphic process. BMC Microbiol. 2007;7:29.
55. Burnie JP, Carter TL, Hodgetts SJ, Matthews RC. Fungal heat-shock proteins in human disease. FEMS Microbiol Rev. 2006;30:53-88.
56. Kummasook A, Pongpom P, Vanittanakom N. Cloning, characterization and differential expression of an hsp70 gene from the pathogenic dimorphic fungus, Penicillium marneffei. DNA Seq. 2007;18:385-94.
57. Chandler JM, Treece ER, Trenary HR, et al. Protein profiling of the dimorphic, pathogenic fungus Penicillium marneffei. Proteome Sci. 2008;6:17.
58. Cooper CR, Vanittanakom N. Insights into the pathogenicity of Penicillium marneffei. Future Microbiol. 2008;3:43-55.
59. Vanittanakom N, Pongpom M, Praparattanapan J, Cooper Jr. CR, Sirisanthana T. Isolation and expression of heat shock protein 30 gene from Penicillium marneffei. Med Mycol. 2009;47:521-6.
60. Bhardwaj S, Shukla A, Mukherjee S, et al. Putative structure and characteristics of a red water-soluble pigment secreted by Penicillium marneffei. Med Mycol. 2007;45:419-27.
61. Nosanchuk JD, Casadevall A. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother. 2006;50:3519-28.
62. Youngchim S, Hay RJ, Hamilton AJ. Melanization of Penicillium marneffei in vitro and in vivo. Microbiology. 2005;151:291-9.
63. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis. 2002;34:277-84.
64. Vanittanakom N, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Curr Top Med Mycol. 1997;8:35-42.
65. Vanittanakom N, Merz WG, Nelson KE, Sirisanthana T. Rapid detection of Penicillium marneffei by polymerase chain reaction/hybridization technique. 13th Congress of International Society for Human and Animal Mycology, Parma, Italy, 8-13 June 1997.
66. Sirisanthana V, Sirisanthana T. Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1995;14:935-40.
67. Yuen WC, Chan YF, Loke SL, Seto WH, Poon GP, Wong KK. Chronic lymphadenopathy caused by Penicillium marneffei: A condition mimicking tuberculous lympadenopathy. Br J Surg. 1986;73:1007-8.
68. Chan YF, Woo KC. Penicillium marneffei osteomyelitis. J Bone Joint Surg Br. 1990;72:500-3.
69. Chan JK, Tsang DN, Wong DK. Penicillium marneffei in bronchoalveolar lavage fluid. Acta Cytol. 1989;33:523-6.
70. Supparatpinyo K, Sirisanthana T. Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection. Clin Infect Dis. 1994;18:246-7.
71. Ko KF. Retropharyngeal abscess caused by Penicillium marneffei: An unusual cause of upper airway obstruction. Otolaryngol Head Neck Surg. 1994;110:445-6.
72. Chim CS, Fong CY, Ma SK, Wong SS, Yuen KY. Reactive hemophagocytic syndrome associated with Penicillium marneffei infection. Am J Med. 1998;104:196-7.
73. Tong AC, Wong M, Smith NJ. Penicillium marneffei infection presenting as oral ulcerations in a patient infected with human immunodeficiency virus. J Oral Maxillofac Surg. 2001;59:953-6.
74. Annam V, Inamadar AC, Palit A, Koppad M, Peerapur BV, Yelikar BR. Genital ulcer caused by Penicillium marneffei in an HIVinfected patient. Sex Transm Infect. 2007;83:249-50.
75. Cooper Jr. CR, Haycocks NG. Penicillium marneffei: An insurgent species among the penicillia. J Eukaryot Microbiol. 2000;47:24-8.
76. Wong SSY, Wong KH, Hui WT, et al. Differences in clinical and laboratory diagnostics characteristics of Penicilliosis marneffei in human immunodeficiency virus (HIV) and non-HIV infected patients. J Clin Microbiol. 2001;39:4534-40.
77. Viviani MA, Tortoranto AM. Penicillium marneffei. In: Ajello L, Hay RJ, editors. Topley and Wilson's microbiology and microbial infections. 9th ed. London, UK: Arnold Press; 1998. p. 409-19.
78. Hsiue HC, Huang YT, Kuo YL, Liao CH, Chang TC, Hsueh PR. Rapid identification of fungal pathogens in positive blood cultures using oligonucleotide array hybridization. Clin Microbiol Infect. 2010;16(5):493-500. 15 July 2009 (Epub ahead of print).
79. Pongpom M, Sirisanthana T, Vanittanakom N. Application of nested PCR to detect Penicillium marneffei in serum samples. Med Mycol. 2009;47:549-53.
80. Pornprasert S, Praparattanapan J, Khamwan C, et al. Development of TaqMan real-time polymerase chain reaction for the detection and identification of Penicillium marneffei. Mycoses. 2009;52:487-92.
81. Zeng H, Li X, Chen X, et al. Identification of Penicillium marneffei in paraffin-embedded tissue using nested PCR. Mycopathologia. 2009;168:31-5.
82. Sekhon AS, Garg AK, Padhye AA, Standard PG, Kaufman L, Ajello L. Antigenic relationship of Penicillium marneffei to P. primulinum. J Med Vet Mycol. 1989;27:105-12.
83. Estrada JA, Stynen D, Cutsem JV, Pierar-Franchimont C, Pierard GE. Immunohistochemical identification of Penicillium marneffei by monoclonal antibody. Dermatol. 1992;31:410-2.
84. Kaufman L, Standard PG, Anderson SA, Jalbert M, Swisher BL. Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei. J Clin Microbiol. 1995;33:2136-8.
85. Sekhon AS, Stein L, Garg AK, Black WA, Glezos JD, Wong C. Pulmonary penicillosis marneffei: report of the first imported case in Canada. Mycopathologia. 1994;128:3-7.
86. Kaufman L, Standard PG, Jalbert M, Kantipong P, Limpakarnjanarat K, Mastro TD. Diagnostic antigenemia tests for Penicilliosis marneffei. J Clin Microbiol. 1996;34:2503-5.
87. Yuen K, Wong SS, Tsang DN, Cau PY. Serodiagnosis of Penicillium marneffei infection. Lancet. 1994;344:444-5.
88. Cao L, Chen DL, Lee C, et al. Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis. J Clin Microbiol. 1998;36:3028-31.
89. Vanittanakom N, Mekaprateep M, Sittisombut N, et al. Western immunoblot analysis of protein antigens of Penicillium marneffei. J Med Vet Mycol. 1997;35:123-31.
90. Jeavons L, Hamilton AJ, Vanittanakom N, et al. Identification and purification of specific Penicillium marneffei antigens and their recognition by human immune sera. J Clin Microbiol. 1998;36:949-54.
91. Chongtrakool P, Chaiyaroj SC, Vithayasai V, et al. Immunoreactivity of a 38-kilodalton Penicillium marneffei antigen with human immunodeficiency virus-positive sera. J Clin Microbiol. 1997;35:2220-3.
92. Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis. 1997;24:1169-71.
93. Desakorn V, Smith MD, Walsh AL, et al. Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay. J Clin Microbiol. 1999;37:117-21.
94. Desakorn V, Simpson AJ, Wuthiekanun V, et al. Development and evaluation of rapid urinary antigen detection tests for diagnosis of Penicilliosis marneffei. J Clin Microbiol. 2002;40:3179-83.
95. Huang YT, Hung CC, Liao CH, Sun HY, Chang SC, Chen YC. Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. J Clin Microbiol. 2007;45:2858-62.
96. Tsunemi Y, Takahashi T, Tamaki T. Penicillium marneffei infection diagnosed by polymerase chain reaction from the skin specimen. J Am Acad Dermatol. 2003;49:344-6.
97. Vanittanakom N, Merz WG, Sittisombut N, Khamwan C, Nelson KE, Sirisanthana T. Specific identification of Penicillium marneffei by a polymerase chain reaction/hybridization technique. Med Mycol. 1998;36:169-75.
98. Vanittanakom N, Vanittanakom P, Hay RJ. Rapid identification of Penicillium marneffei by PCR-based detection of specific sequences on the rRNA gene. J Clin Microbiol. 2002; 40:1739-42.
99. Vanittanakom N, Cooper Jr. CR, Chariyalertsak S, Youngchim S, Nelson KE, Sirisanthana T. Restriction endonuclease analysis of Penicillium marneffei. J Clin Microbiol. 1996;34:1834-6.
100. Trewatcharegon S, Sirisinha S, Romsai A, Eampokalap B, Teanpaisan R, Chaiyaroj SC. Molecular typing of Penicillium marneffei isolates from Thailand by NotI macrorestriction and pulsed-field gel electrophoresis. J Clin Microbiol. 2001; 39:4544-8.
101. Hsueh PR, Teng LJ, Hung CC, et al. Molecular evidence for strain dissemination of Penicillium marneffei: An emerging pathogen in Taiwan. J Infect Dis. 2000;181:1706-12.
102. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virusinfected patients. Clin Infect Dis. 1998;26:1107-10.
103. Supparatpinyo K, Chiewchanvit S, Hirunsri P, et al. An efficacy study of itraconazole in the treatment of Penicillium marneffei infection. J Med Assoc Thailand. 1992;75:688-91.
104. Supparatpinyo K, Schlamm HT. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients. Am J Trop Med Hyg. 2007;77:350-3.
105. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58:1-207.
106. Gupta S, Mathur P, Maskey D, Wig N, Singh S. Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient. AIDS Res Ther. 2007;4:21.
107. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Infect. 2007;55:464-9.
108. Saikia L, Nath R, Biswanath P, Hazarika D, Mahanta J. Penicillium marneffei infection in HIV infected patients in Nagaland & immune reconstitution after treatment. Indian J Med Res. 2009;129:333-4.
109. Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N Engl J Med. 1998;339:1739-43.
110. Chaiwarith R, Charoenyos N, Sirisanthana T, Supparatpinyo K. Discontinuation of secondary prophylaxis against Penicilliosis marneffei in AIDS patients after HAART. AIDS. 2007;21:365-7.
111. Lopez Bernaldo de Quiros JC, Miro JM, Pena JM, et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98. N Engl J Med. 2001;344:159-67.
112. Rollot F, Bossi P, Tubiana R, et al. Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy. AIDS. 2001; 15:1448-9.
113. Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis. 2004;38:1485-9.